According to the latest research analysis,the global market for Allele should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Allele market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Allele market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Dominant segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Solving Crimes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Allele include Allele Biotechnology, Generi Biotech, Spark Therapeutics, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, SQZ Biotechnologies, Novartis Gene Therapies, Asklepios BioPharmaceutical, Inc. and Cellectis, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
A variation of the same sequence of nucleotides at the same place on a long DNA molecule, as described in leading textbooks on genetics and evolution.
This report aims to provide a comprehensive study of the global market for Allele.
Data-Driven Insights: Highlights from Our Report
(1) Global Allele market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Allele market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Allele market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Allele segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Allele segment by type and by application and regional segment by type and by application.
(6) Allele industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Dominant
Recessive
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Solving Crimes
Determining Paternity
Exploring one's Ancestry
Others
Understanding Market Segments by Key Players: Insights and Opportunities
Allele Biotechnology
Generi Biotech
Spark Therapeutics
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
SQZ Biotechnologies
Novartis Gene Therapies
Asklepios BioPharmaceutical, Inc.
Cellectis
Pluristem Therapeutics Inc.
1 Market Overview
1.1 Product Overview and Scope of Allele
1.2 Global Allele Market Size and Forecast
1.3 China Allele Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Allele Share in Global Market, 2018-2029
1.4.2 Allele Market Size: China VS Global, 2018-2029
1.5 Allele Market Dynamics
1.5.1 Allele Market Drivers
1.5.2 Allele Market Restraints
1.5.3 Allele Industry Trends
1.5.4 Allele Industry Policy
2 Global Competitive Situation by Company
2.1 Global Allele Revenue by Company (2018-2023)
2.2 Global Allele Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Allele Concentration Ratio
2.4 Global Allele Mergers & Acquisitions, Expansion Plans
2.5 Global Allele Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Allele Revenue by Company (2018-2023)
3.2 China Allele Allele Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Allele, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Allele Industry Chain
4.2 Allele Upstream Analysis
4.3 Allele Midstream Analysis
4.4 Allele Downstream Analysis
5 Sights by Type
5.1 Allele Classification
5.1.1 Dominant
5.1.2 Recessive
5.2 By Type, Global Allele Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Allele Revenue, 2018-2029
6 Sights by Application
6.1 Allele Segment by Application
6.1.1 Solving Crimes
6.1.2 Determining Paternity
6.1.3 Exploring one's Ancestry
6.1.4 Others
6.2 By Application, Global Allele Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Allele Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Allele Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Allele Market Size, 2018-2029
7.3 North America
7.3.1 North America Allele Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Allele Market Size Market Share
7.4 Europe
7.4.1 Europe Allele Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Allele Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Allele Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Allele Market Size Market Share
7.6 South America
7.6.1 South America Allele Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Allele Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Allele Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Allele Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Allele Market Size, 2018-2029
8.3.2 By Company, U.S. Allele Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Allele Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Allele Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Allele Market Size, 2018-2029
8.4.2 By Company, Europe Allele Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Allele Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Allele Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Allele Market Size, 2018-2029
8.5.2 By Company, China Allele Revenue Market Share, 2018-2023
8.5.3 By Type, China Allele Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Allele Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Allele Market Size, 2018-2029
8.6.2 By Company, Japan Allele Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Allele Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Allele Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Allele Market Size, 2018-2029
8.7.2 By Company, South Korea Allele Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Allele Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Allele Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Allele Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Allele Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Allele Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Allele Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Allele Market Size, 2018-2029
8.9.2 By Company, India Allele Revenue Market Share, 2018-2023
8.9.3 By Type, India Allele Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Allele Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Allele Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Allele Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Allele Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Allele Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Allele Biotechnology
9.1.1 Allele Biotechnology Company Information, Head Office, Market Area and Industry Position
9.1.2 Allele Biotechnology Company Profile and Main Business
9.1.3 Allele Biotechnology Allele Models, Specifications and Application
9.1.4 Allele Biotechnology Allele Revenue and Gross Margin, 2018-2023
9.1.5 Allele Biotechnology Recent Developments
9.2 Generi Biotech
9.2.1 Generi Biotech Company Information, Head Office, Market Area and Industry Position
9.2.2 Generi Biotech Company Profile and Main Business
9.2.3 Generi Biotech Allele Models, Specifications and Application
9.2.4 Generi Biotech Allele Revenue and Gross Margin, 2018-2023
9.2.5 Generi Biotech Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Spark Therapeutics Company Profile and Main Business
9.3.3 Spark Therapeutics Allele Models, Specifications and Application
9.3.4 Spark Therapeutics Allele Revenue and Gross Margin, 2018-2023
9.3.5 Spark Therapeutics Recent Developments
9.4 Alnylam Pharmaceuticals
9.4.1 Alnylam Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.4.2 Alnylam Pharmaceuticals Company Profile and Main Business
9.4.3 Alnylam Pharmaceuticals Allele Models, Specifications and Application
9.4.4 Alnylam Pharmaceuticals Allele Revenue and Gross Margin, 2018-2023
9.4.5 Alnylam Pharmaceuticals Recent Developments
9.5 Arrowhead Pharmaceuticals
9.5.1 Arrowhead Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.5.2 Arrowhead Pharmaceuticals Company Profile and Main Business
9.5.3 Arrowhead Pharmaceuticals Allele Models, Specifications and Application
9.5.4 Arrowhead Pharmaceuticals Allele Revenue and Gross Margin, 2018-2023
9.5.5 Arrowhead Pharmaceuticals Recent Developments
9.6 SQZ Biotechnologies
9.6.1 SQZ Biotechnologies Company Information, Head Office, Market Area and Industry Position
9.6.2 SQZ Biotechnologies Company Profile and Main Business
9.6.3 SQZ Biotechnologies Allele Models, Specifications and Application
9.6.4 SQZ Biotechnologies Allele Revenue and Gross Margin, 2018-2023
9.6.5 SQZ Biotechnologies Recent Developments
9.7 Novartis Gene Therapies
9.7.1 Novartis Gene Therapies Company Information, Head Office, Market Area and Industry Position
9.7.2 Novartis Gene Therapies Company Profile and Main Business
9.7.3 Novartis Gene Therapies Allele Models, Specifications and Application
9.7.4 Novartis Gene Therapies Allele Revenue and Gross Margin, 2018-2023
9.7.5 Novartis Gene Therapies Recent Developments
9.8 Asklepios BioPharmaceutical, Inc.
9.8.1 Asklepios BioPharmaceutical, Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Asklepios BioPharmaceutical, Inc. Company Profile and Main Business
9.8.3 Asklepios BioPharmaceutical, Inc. Allele Models, Specifications and Application
9.8.4 Asklepios BioPharmaceutical, Inc. Allele Revenue and Gross Margin, 2018-2023
9.8.5 Asklepios BioPharmaceutical, Inc. Recent Developments
9.9 Cellectis
9.9.1 Cellectis Company Information, Head Office, Market Area and Industry Position
9.9.2 Cellectis Company Profile and Main Business
9.9.3 Cellectis Allele Models, Specifications and Application
9.9.4 Cellectis Allele Revenue and Gross Margin, 2018-2023
9.9.5 Cellectis Recent Developments
9.10 Pluristem Therapeutics Inc.
9.10.1 Pluristem Therapeutics Inc. Company Information, Head Office, Market Area and Industry Position
9.10.2 Pluristem Therapeutics Inc. Company Profile and Main Business
9.10.3 Pluristem Therapeutics Inc. Allele Models, Specifications and Application
9.10.4 Pluristem Therapeutics Inc. Allele Revenue and Gross Margin, 2018-2023
9.10.5 Pluristem Therapeutics Inc. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|